Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Zhou, Yujie"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-32 z 32
    Tytuł:
    Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.
    Autorzy:
    Ji Q; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China ; Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
    Zeng Q; Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
    Huang Y; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
    Shi Y; Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
    Lin Y; Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
    Lu Z; Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
    Meng K; Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
    Wu B; Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
    Yu K; Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
    Chai M; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
    Liu Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
    Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
    Pokaż więcej
    Źródło:
    Mediators of inflammation [Mediators Inflamm] 2014; Vol. 2014, pp. 165742. Date of Electronic Publication: 2014 Mar 06.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Acute Coronary Syndrome/*blood
    Intercellular Signaling Peptides and Proteins/*blood
    Interleukin-1/*blood
    Interleukin-18/*blood
    Acute Disease ; Aged ; Angina Pectoris/blood ; C-Reactive Protein/metabolism ; Coronary Angiography ; Echocardiography, Doppler ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Leukocytes, Mononuclear/cytology ; Male ; Middle Aged ; Myocardial Infarction/blood ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Ventricular Function, Left
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris.
    Autorzy:
    Ji Q
    Lin Y
    Liang Z
    Yu K
    Liu Y
    Fang Z
    Liu L
    Shi Y
    Zeng Q
    Chang C
    Chai M
    Zhou Y
    Pokaż więcej
    Źródło:
    Cardiovascular diabetology [Cardiovasc Diabetol] 2014 Nov 01; Vol. 13, pp. 145. Date of Electronic Publication: 2014 Nov 01.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Acute Coronary Syndrome/*blood
    Chemokines/*blood
    Adiponectin/blood ; Adult ; Aged ; Aged, 80 and over ; Angina, Stable/blood ; Biomarkers/blood ; Female ; Humans ; Intercellular Signaling Peptides and Proteins ; Male ; Middle Aged ; Myocardial Infarction/blood
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
    Autorzy:
    Wang L; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
    Peng P; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
    Zhang O; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
    Xu X; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
    Yang S; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
    Zhao Y; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
    Zhou Y; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2014 Dec 04; Vol. 9 (12), pp. e113352. Date of Electronic Publication: 2014 Dec 04 (Print Publication: 2014).
    Typ publikacji:
    Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Elective Surgical Procedures*
    Acute Coronary Syndrome/*drug therapy
    Hydroxymethylglutaryl-CoA Reductase Inhibitors/*administration & dosage
    Myocardial Infarction/*drug therapy
    Acute Coronary Syndrome/epidemiology ; Acute Coronary Syndrome/surgery ; Humans ; Myocardial Infarction/epidemiology ; Myocardial Infarction/surgery ; Percutaneous Coronary Intervention/methods ; PubMed ; Randomized Controlled Trials as Topic ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Transradial Approach for STEMI: A General View
    Autorzy:
    Ludwig, Josef
    Pokaż więcej
    Źródło:
    Transradial Approach for Percutaneous Interventions. :105-110
    Książka elektroniczna
    Szczegóły
    Tytuł:
    Gender-specific associations between atherogenic index of plasma and the presence and severity of acute coronary syndrome in very young adults: a hospital-based observational study.
    Autorzy:
    Cai G; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.; Department of Cardiology, Wujin Hospital affiliated with Jiangsu University, Changzhou, 213017, Jiangsu, China.
    Liu W; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Lv S; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Wang X; Emergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
    Guo Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Yan Z; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Du Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Zhou Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China. .
    Pokaż więcej
    Źródło:
    Lipids in health and disease [Lipids Health Dis] 2019 Apr 13; Vol. 18 (1), pp. 99. Date of Electronic Publication: 2019 Apr 13.
    Typ publikacji:
    Journal Article; Observational Study
    MeSH Terms:
    Acute Coronary Syndrome/*blood
    Angina, Unstable/*blood
    Atherosclerosis/*blood
    Myocardial Infarction/*blood
    Acute Coronary Syndrome/diagnostic imaging ; Acute Coronary Syndrome/physiopathology ; Adult ; Age of Onset ; Angina, Unstable/diagnostic imaging ; Angina, Unstable/physiopathology ; Atherosclerosis/diagnostic imaging ; Atherosclerosis/physiopathology ; Case-Control Studies ; China ; Cholesterol, HDL/blood ; Cholesterol, LDL/blood ; Coronary Angiography ; Female ; Hospitals ; Humans ; Logistic Models ; Male ; Myocardial Infarction/diagnostic imaging ; Myocardial Infarction/physiopathology ; Risk Factors ; Severity of Illness Index ; Sex Factors ; Triglycerides/blood
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Aortic Arch Calcification Is a Strong Predictor of the Severity of Coronary Artery Disease in Patients with Acute Coronary Syndrome.
    Autorzy:
    Ma X; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.
    Hou F; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.; Department of Cardiology, Qingdao Municipal Hospital, Qingdao 266000, China.
    Tian J; Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
    Zhou Z; Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
    Ma Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.
    Cheng Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.
    Du Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.
    Shen H; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.
    Hu B; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.
    Wang Z; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.
    Liu Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.
    Zhao Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.
    Zhou Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing 100029, China.
    Pokaż więcej
    Źródło:
    BioMed research international [Biomed Res Int] 2019 Aug 07; Vol. 2019, pp. 7659239. Date of Electronic Publication: 2019 Aug 07 (Print Publication: 2019).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Acute Coronary Syndrome/*pathology
    Aorta, Thoracic/*pathology
    Coronary Artery Disease/*pathology
    Vascular Calcification/*pathology
    Coronary Angiography/methods ; Female ; Humans ; Male ; Middle Aged ; Odds Ratio ; ROC Curve ; Risk Factors ; Sensitivity and Specificity ; Severity of Illness Index
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Autorzy:
    Ma X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China.
    Dong L; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China.
    Shao Q; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China.
    Cheng Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China.
    Lv S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China.
    Sun Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China.
    Shen H; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China.
    Wang Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China.
    Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China.
    Liu X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Beijing, 100029, China. .
    Pokaż więcej
    Źródło:
    Cardiovascular diabetology [Cardiovasc Diabetol] 2020 Mar 10; Vol. 19 (1), pp. 31. Date of Electronic Publication: 2020 Mar 10.
    Typ publikacji:
    Journal Article; Observational Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Percutaneous Coronary Intervention*/adverse effects
    Percutaneous Coronary Intervention*/mortality
    Acute Coronary Syndrome/*therapy
    Blood Glucose/*analysis
    Diabetes Mellitus, Type 2/*blood
    Triglycerides/*blood
    Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/diagnosis ; Acute Coronary Syndrome/mortality ; Aged ; Biomarkers/blood ; Cause of Death ; Diabetes Mellitus, Type 2/diagnosis ; Diabetes Mellitus, Type 2/mortality ; Female ; Humans ; Insulin Resistance ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Characteristics of culprit lesions in young patients with metabolic syndrome and classic cardiovascular risk factors.
    Autorzy:
    Hou, Fangjie (AUTHOR)
    Zhou, Yujie (AUTHOR)
    Liu, Wei (AUTHOR)
    Yang, Shiwei (AUTHOR)
    Wang, Zhijian (AUTHOR)
    Ma, Xiaoteng (AUTHOR)
    Du, Yu (AUTHOR)
    Li, Ya (AUTHOR)
    Guan, Jun (AUTHOR)
    Pokaż więcej
    Źródło:
    Experimental & Therapeutic Medicine. Apr2020, Vol. 19 Issue 4, p2766-2772. 7p.
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Autorzy:
    Ma X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Sun Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Cheng Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Shen H; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Gao F; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Qi J; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Yang L; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Wang Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Shi D; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Liu Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Liu X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China. .
    Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China. .
    Pokaż więcej
    Źródło:
    Lipids in health and disease [Lipids Health Dis] 2020 Nov 16; Vol. 19 (1), pp. 240. Date of Electronic Publication: 2020 Nov 16.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Prognosis*
    Acute Coronary Syndrome/*blood
    Atherosclerosis/*blood
    Diabetes Mellitus, Type 2/*blood
    Acute Coronary Syndrome/complications ; Acute Coronary Syndrome/epidemiology ; Acute Coronary Syndrome/surgery ; Aged ; Atherosclerosis/complications ; Atherosclerosis/epidemiology ; Atherosclerosis/surgery ; Cholesterol, HDL/blood ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/surgery ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/methods ; Risk Factors ; Triglycerides/blood
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Associations between hyperhomocysteinemia and the presence and severity of acute coronary syndrome in young adults ≤ 35 years of age.
    Autorzy:
    Sun, Jiayin
    Han, Wei
    Wu, Sijing
    Jia, Shuo
    Yan, Zhenxian
    Guo, Yonghe
    Zhao, Yingxin
    Zhou, Yujie
    Liu, Wei
    Pokaż więcej
    Temat:
    ACUTE coronary syndrome
    YOUNG adults
    CORONARY artery stenosis
    HYPERHOMOCYSTEINEMIA
    MYOCARDIAL infarction
    Źródło:
    BMC Cardiovascular Disorders; 1/23/2021, Vol. 21 Issue 1, p1-10, 10p
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Relationship between coronary hyper-intensive plaques identified by cardiovascular magnetic resonance and clinical severity of acute coronary syndrome.
    Autorzy:
    Liu, Wen
    Wu, Sijing
    Wang, Zhenjia
    Du, Yanni
    Fan, Zhaoyang
    Dong, Li
    Guo, Yonghe
    Liu, Yi
    Bi, Xiaoming
    An, Jing
    Zhou, Yujie
    Liu, Wei
    Li, Debiao
    Yu, Wei
    Xie, Yibin
    Pokaż więcej
    Źródło:
    Journal of Cardiovascular Magnetic Resonance (BioMed Central). 2/24/2021, Vol. 23 Issue 1, p1-10. 10p.
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial.
    Autorzy:
    Xu, Bo (AUTHOR)
    Tu, Shengxian (AUTHOR)
    Song, Lei (AUTHOR)
    Jin, Zening (AUTHOR)
    Yu, Bo (AUTHOR)
    Fu, Guosheng (AUTHOR)
    Zhou, Yujie (AUTHOR)
    Wang, Jian'an (AUTHOR)
    Chen, Yundai (AUTHOR)
    Pu, Jun (AUTHOR)
    Chen, Lianglong (AUTHOR)
    Qu, Xinkai (AUTHOR)
    Yang, Junqing (AUTHOR)
    Liu, Xuebo (AUTHOR)
    Guo, Lijun (AUTHOR)
    Shen, Chengxing (AUTHOR)
    Zhang, Yaojun (AUTHOR)
    Zhang, Qi (AUTHOR)
    Pan, Hongwei (AUTHOR)
    Fu, Xiaogang (AUTHOR)
    Pokaż więcej
    Źródło:
    Lancet. Dec2021, Vol. 398 Issue 10317, p2149-2159. 11p.
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
    Autorzy:
    Liu C; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Zhao Q; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Ma X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Cheng Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Sun Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Zhang D; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China.
    Liu X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China. .
    Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, 100029, China. .
    Pokaż więcej
    Źródło:
    Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Jan 19; Vol. 21 (1), pp. 11. Date of Electronic Publication: 2022 Jan 19.
    Typ publikacji:
    Journal Article; Observational Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Percutaneous Coronary Intervention*/adverse effects
    Percutaneous Coronary Intervention*/instrumentation
    Percutaneous Coronary Intervention*/mortality
    Acute Coronary Syndrome/*therapy
    Diabetes Mellitus, Type 2/*blood
    Glycated Hemoglobin/*metabolism
    Non-ST Elevated Myocardial Infarction/*therapy
    Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/diagnosis ; Acute Coronary Syndrome/mortality ; Aged ; Beijing ; Biomarkers/blood ; Diabetes Mellitus, Type 2/diagnosis ; Diabetes Mellitus, Type 2/mortality ; Female ; Humans ; Ischemic Stroke/etiology ; Male ; Middle Aged ; Non-ST Elevated Myocardial Infarction/blood ; Non-ST Elevated Myocardial Infarction/diagnosis ; Non-ST Elevated Myocardial Infarction/mortality ; Predictive Value of Tests ; Recurrence ; Retreatment ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Stents ; Time Factors ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Effect of Presence versus Absence of Hypertension on Admission Heart Rate-Associated Cardiovascular Risk in Patients with Acute Coronary Syndrome.
    Autorzy:
    Xia, Yihua
    Wang, Zhijian
    Gao, Fei
    Yang, Lixia
    Liang, Jing
    Shi, Dongmei
    Zhou, Yujie
    Ma, Xiaoteng
    Pokaż więcej
    Temat:
    HYPERTENSION
    CARDIOVASCULAR diseases risk factors
    PERCUTANEOUS coronary intervention
    STROKE
    CONFIDENCE intervals
    MULTIVARIATE analysis
    ACUTE coronary syndrome
    MYOCARDIAL infarction
    REGRESSION analysis
    HEART beat
    Źródło:
    International Journal of Hypertension; 2/14/2022, p1-7, 7p
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Predictive worth of estimated glucose disposal rate: evaluation in patients with non-ST-segment elevation acute coronary syndrome and non-diabetic patients after percutaneous coronary intervention.
    Autorzy:
    Liu, Chi (AUTHOR)
    Liu, Xiaoli (AUTHOR)
    Ma, Xiaoteng (AUTHOR)
    Cheng, Yujing (AUTHOR)
    Sun, Yan (AUTHOR)
    Zhang, Dai (AUTHOR)
    Zhao, Qi (AUTHOR)
    Zhou, Yujie (AUTHOR)
    Pokaż więcej
    Źródło:
    Diabetology & Metabolic Syndrome. 10/6/2022, Vol. 14 Issue 1, p1-12. 12p.
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Autorzy:
    Han, Kangning
    Shi, Dongmei
    Yang, Lixia
    Wang, Zhijian
    Li, Yueping
    Gao, Fei
    Liu, Yuyang
    Ma, Xiaoteng
    Zhou, Yujie
    Pokaż więcej
    Temat:
    MYOCARDIAL infarction
    PERCUTANEOUS coronary intervention
    ACUTE coronary syndrome
    PROGNOSIS
    DRUG-eluting stents
    MAJOR adverse cardiovascular events
    INFLAMMATION
    Źródło:
    Annals of Medicine; Dec2022, Vol. 54 Issue 1, p1667-1677, 11p
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
    Autorzy:
    Dong S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Zhao Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Huang X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Ma M; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Yang Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Fan C; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Han H; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Wang Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Shi D; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
    Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China. .
    Pokaż więcej
    Źródło:
    Cardiovascular diabetology [Cardiovasc Diabetol] 2023 Oct 27; Vol. 22 (1), pp. 286. Date of Electronic Publication: 2023 Oct 27.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Acute Coronary Syndrome*/diagnosis
    Acute Coronary Syndrome*/surgery
    Percutaneous Coronary Intervention*/adverse effects
    Stroke*/diagnosis
    Stroke*/etiology
    Coronary Artery Disease*/etiology
    Humans ; Glucose ; Triglycerides ; Retrospective Studies ; Coronary Artery Bypass/adverse effects ; Risk Factors ; Prognosis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-32 z 32

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies